Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation
eLife · 13.09.2024 · 12
DOI: 10.7554/elife.87935 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 13.09.2024. Verfasst von Jiansen Lu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery, the Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Autophagy, Sepsis, Signal Transduction, Transcription Factor RelA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Guangdong Basic and Applied Basic Research Foundation.
Themen: Sepsis
Abstract (Originalsprache)
Van Gogh-like 2 (Vangl2), a core planar cell polarity component, plays an important role in polarized cellular and tissue morphology induction, growth development, and cancer. However, its role in regulating inflammatory responses remains elusive. Here, we report that Vangl2 is upregulated in patients with sepsis and identify Vangl2 as a negative regulator of The nuclear factor-kappaB (NF-κB) signaling by regulating the protein stability and activation of the core transcription component p65. Mice with myeloid-specific deletion of Vangl2 ( Vangl2 ΔM ) are hypersusceptible to lipopolysaccharide (LPS)-induced septic shock. Vangl2-deficient myeloid cells exhibit enhanced phosphorylation and expression of p65, therefore, promoting the secretion of proinflammatory cytokines after LPS stimulation. Mechanistically, NF-κB signaling-induced-Vangl2 recruits E3 ubiquitin ligase PDLIM2 to catalyze K63-linked ubiquitination on p65, which serves as a recognition signal for cargo receptor NDP52-mediated selective autophagic degradation. Taken together, these findings demonstrate Vangl2 as a suppressor of NF-κB-mediated inflammation and provide insights into the crosstalk between autophagy and inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Joint Surgery, the Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
- Department of Clinical Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Department of Orthopaedics, Yuebei People's Hospital Affiliated to Medical College of Shantou University, Shaoguan, China.
- Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
- Institute of Biosciences and Technology, College of Medicine, Texas A&M University, Houston, United States.
ORCID-Profile: Jiansen Lu, Hongyu Li, Xiaochun Bai, Xiao Yu
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Lu, J., Zhang, J., Jiang, H., Hu, Z., Zhang, Y., He, L., Yang, J., Xie, Y., Wu, D., Li, H., Zeng, K., Tan, P., Xiao, Q., Song, Z., Pan, C., Bai, X., & Yu, X. (2024). Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation. eLife, 12. https://doi.org/10.7554/elife.87935
Vancouver
Lu J, Zhang J, Jiang H, Hu Z, Zhang Y, He L, et al. Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation. eLife. 2024;12. doi:10.7554/elife.87935
BibTeX
@article{Lu2024,
author = {Lu, Jiansen and Zhang, Jiahuan and Jiang, Huaji and Hu, Zhiqiang and Zhang, Yufen and He, Lian and Yang, Jianwu and Xie, Yingchao and Wu, Dan and Li, Hongyu and Zeng, Ke and Tan, Peng and Xiao, Qingyue and Song, Zijing and Pan, Chenglong and Bai, Xiaochun and Yu, Xiao},
title = {Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation},
journal = {eLife},
year = {2024},
volume = {12},
doi = {10.7554/elife.87935}
}
EUVIMED